Leading investors and industry experts provide mentorship and guidance to the companies on product, growth strategy and fundraising.
Activate Venture Partners is an early-stage venture capital firm for high-growth technology companies.
Deerfield is a leading investment management firm committed to advancing healthcare through investment, information and philanthropy.
Deerfield was launched in 1994 with approximately $17 million in capital and, as of January 2014, manages funds in excess of $3.5 billion. It is a relationship-focused, non-activist firm that is committed to helping the companies in which it invests to realize their potential for advancing healthcare and driving change in this crucial industry. Deerfield’s comprehensive understanding of healthcare assets allows it to appreciate opportunity even when complex financial, legislative, regulatory and competitive pressures are present. Collaboration, intellectual curiosity and pragmatism define its approach.
Deerfield has over 70 full-time professionals who bring many decades of experience across all sub-sectors of healthcare in order to deliver innovative funding solutions to the firm’s financing partners.
New Leaf Venture Partners is a leading healthcare technology investor, managing approximately $1 billion in funds, and investments in 45 companies. They focus on 3 sectors: biopharmaceuticals, medical devices, and diagnostic/infrastructure technologies. Their goal is to build strong companies by supporting exceptional teams in the development of clinically important and commercially attractive products.
Across all sectors and stages, their investment decisions are primarily driven by a fundamental assessment of the risks in the underlying development programs (e.g., technical, clinical, regulatory, and commercial risks). Before making an investment, they work with the management teams to identify key milestones that must be met to reach points of meaningful value inflection, and they ensure that adequate resources are provided for the company to achieve those milestones.
The NLV investment team has deep operating experience and medical and technical expertise which are integral to their active investment approach. This allows them to work closely with founders, management, and co-investors to identify and execute on a capital efficient and optimal path to value creation and exit. This focused and fundamentals driven investment approach generates attractive returns for their investors.
NLV Partners has offices in New York and Menlo Park, California. They are currently making new investments through New Leaf Ventures II, a $450 million fund, which started its investing cycle in mid–2008.
The Partnership Fund for New York City was founded by Henry Kravis of Kohlberg Kravis Roberts & Co. in 1996 with funding from New York’s leaders of business and finance. The Partnership Fund mobilizes its investors resource—their money, time and influence—to create jobs, spur new business creation and to expand opportunities for all of the city’s residents and neighborhoods. An “evergreen” fund, realized gains are continuously reinvested. Since inception, the Fund has invested in excess of $150 million. Investments are made only in New York City-based enterprises principally in the areas of digital health, financial technology, life sciences, advanced manufacturing, healthcare, workforce development and food manufacturing.
SPG is a consulting firm that advises health care leaders on the direction health care is heading in the states and across the nation. SPG also provides its clients with unique, personalized strategies to achieve success, such as finding funding opportunities or developing business strategies and partnerships. SPG is not a lobbying firm.
SPG’s clients include major hospitals and health systems, technology companies, long-term care organizations, human service agencies, labor unions, behavioral health organizations and health plans, among others. In its partnership with Junto Health, SPG provides Junto Health members with guidance on relevant trends in health care policy, health care finance and the delivery of health care services. But Junto Health members are not necessarily clients of SPG nor are Juno Health members afforded the full range of services SPG provides to its clients.
Safeguard Scientifics provides capital and relevant expertise to fuel the growth of technology-driven businesses in healthcare, financial services and digital media. Safeguard targets companies that are capitalizing on the next wave of enabling technologies with a particular focus on the Internet of Everything, enhanced security and predictive analytics. Specifically in healthcare, Safeguard is focused on digital health and selectively on devices and diagnostics. Safeguard typically deploys between $5 million and $25 million over the course of its partnership with a company, initially participating in a Series A or B Round and opportunistically in a Seed Round. Safeguard has a distinguished track record of fostering innovation and building market leaders that spans more than six decades.
Troutman Sanders LLP is an international law firm with more than 650 attorneys practicing in 16 offices located throughout the United States and Asia. The firm’s clients range from large multinational corporations to individual entrepreneurs and reflect virtually every sector and industry. The firm’s heritage of extensive experience, exceptional responsiveness and an unwavering commitment to service has resulted in strong, long-standing relationships with clients across the globe. In recognition of the firm’s strong service culture, Troutman Sanders has been on the BTI Client Service A-Team for 13 consecutive years.